Navigation Links
Astellas Named Elite Winner for Employee Engagement and Commitment in 'Chicago's 101 Best and Brightest Companies to Work For' Competition
Date:8/11/2009

DEERFIELD, Ill., Aug. 11 /PRNewswire/ -- In a ceremony recognizing "Chicago's 101 Best and Brightest Companies to Work For," Astellas Pharma US, Inc. won an Elite award for employee engagement and commitment by the National Association for Business Resources (NABR). Astellas scored high in all 10 categories and was specifically recognized for the high level of employees' engagement and pride in the company.

"At Astellas, we understand that investment in our employees is vital to reaching our corporate goals and it is even more critical in these tough economic times," said Seigo Kashii, president and CEO of Astellas. "Being selected as 'Chicago's 101 Best and Brightest Companies to Work For' further validates our commitment to our employees and being a recognized employer of choice in the Chicago area and the pharmaceutical industry."

"We are honored to recognize the efforts of this year's 101 'Best and Brightest' companies. These companies have created impressive organizational value and business results through their policies and best practices in human resource management. This award has become a powerful recruitment tool in the drive to attract and retain exceptional employees," said Jennifer Kluge, NABR president.

The NABR's annual list of "Best and Brightest Companies" compiles the results of an independent research firm that evaluates each company's entry in the following categories: communication, community initiatives, compensation and benefits, diversity and multiculturalism, employee education and development, employee engagement and commitment, recognition and retention, small business, recruitment and selection, and work-life balance. The judges look for unique and creative thought processes with support from senior management and policy makers.

About Astellas

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the US, Astellas markets products in the areas of Immunology, Urology, Anti-Infectives, Cardiovascular and Dermatology. For more information about Astellas Pharma US, Inc., please visit our website at www.us.astellas.com.

About The National Association for Business Resources

The National Association for Business Resources (NABR) advocates and represents small and medium-sized businesses throughout the United States. NABR specializes in providing businesses the benefits, programs, services, and assistance required to operating as efficiently and successfully as possible. Best practice solutions are available to members in the areas of human resources, healthcare, legal, transaction, compliance, marketing, and office services. For more information about NABR and its offerings, please visit www.nationalbiz.org or call 1-866-321-1822.


'/>"/>
SOURCE Astellas Pharma US, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardiome And Astellas Announce Regulatory Update
2. FDA Approves Additional Indication for Astellas MYCAMINE(R)
3. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
4. Astellas Launches Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
5. Astellas Announces New Vice President of Marketing
6. Astellas Hires New Vice President of Compliance
7. Astellas Adds CNS Therapy Area Leader to Global R&D Team
8. Astellas Names Head of Global R&D Operations
9. NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)
10. AUA Foundation names the 2009 Astellas Rising Stars in Urology award winners
11. Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood ... to the labor and delivery team at Women’s Hospital at Renaissance in Edinburg for ... birth at the hospital and decide to donate. , “Women’s Hospital at Renaissance ...
(Date:4/28/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a ... does not. Yisrayl says with so many titles and names for the Creator, it’s ... with a little Scripture, backed with a lot of research, the truth is undeniable. ...
(Date:4/28/2017)... ... 2017 , ... NuevaCare, a leading home care agency based in San Mateo, ... is proud to announce information upgrades to its blog in the form of WordPress ... topics such as home care (generally) as well as senior care and home care ...
(Date:4/27/2017)... Washington, DC (PRWEB) , ... April 27, 2017 ... ... "Using Behavioral Economics Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a ... and recognition (IRR) field. Offering practical takeaways to apply immediately to IRR programs, ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, ... sponsorship at MobileIron Live! 2017 in Santa Clara, California. Each year, ... educational approach to helping organizations maximize the benefits of mobility in their operations ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  SARES•REGIS Group leased the first of ... Conejo Spectrum Business Park in Thousand ... Inc. , a biopharmaceutical company developing meaningful therapies ... have been underserved by scientific innovation, with an ... autoimmune and infectious disease. Before commencement ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... and Gynecology markets with innovative and proprietary products, will ... 31, 2017 after the market close on Tuesday, May ... a conference call and webcast to discuss its financial ... at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
(Date:4/18/2017)... DUBLIN , April 18, 2017 Research ... Devices Market 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at ... The report, Global Arthroscopy Devices Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology: